| abstract |
The present invention relates to a composite preparation, with various dosage forms, of mosapride and rabeprazole. The composite preparation prepared according to the present invention allows a rapid release of drug without the deterioration of release by an interaction of mosapride and rabeprazole, thereby exhibiting an improved drug release rate and bioavailability and having excellent product stability, and significantly lowers the excipient content, thereby improving drug compatibility of a patient due to the size of the dosage form. |